Immunosuppression Individualization

Immunosuppression Individualization is a clinical decision-making framework that distinguishes itself from standardized immunosuppressive protocols by systematically tailoring drug selection, dosing, and duration to individual patient characteristics, immune risk profiles, and longitudinal response monitoring to optimize graft outcomes while minimizing toxicity.

25

Publications

726

Citations

152

Authors

67

Institutions

Publications per year

2017–2026

7

Variants

Individualized ImmunosuppressionPersonalized Immunosuppression

Authors

152

  1. BD
    B D Kahan

    The University of Texas at Austin, United States

    2 publications · 79 citations

    2

    h-index

  2. AV
    Andrés Valdivieso

    Hospital de Cruces, Spain

    1 publications · 13 citations

    1

    h-index

  3. MZ
    Martin Zeier

    Heidelberg University, Germany

    1 publications · 15 citations

    1

    h-index

  4. SD
    Sabine Daebritz

    Ludwig-Maximilians-Universität München, Germany

    1 publications · 15 citations

    1

    h-index

  5. TW
    Theresa Wolf‐Doty

    PAX Scientific (United States), United States

    1 publications · 14 citations

    1

    h-index

1–5 of 152

Venues

  1. Transplantation

    3 publications · 112 citations

    3

    h-index

  2. Transplantation Proceedings

    3 publications · 104 citations

    3

    h-index

  3. Expert Opinion on Biological Therapy

    1 publications · 14 citations

    1

    h-index

  4. American Journal of Transplantation

    1 publications · 35 citations

    1

    h-index

  5. 1

    h-index

1–5